Pharming Group NV (PHGUF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,492 | -12,012 | 14,987 | 23,078 | 44,094 |
| Depreciation Amortization | 16,070 | 15,925 | 13,188 | 19,610 | 8,314 |
| Accounts receivable | -6,783 | -18,539 | 2,364 | 5,918 | -7,040 |
| Accounts payable and accrued liabilities | -2,769 | 16,228 | 11,992 | -5,193 | 7,019 |
| Other Working Capital | -10,072 | -16,961 | -387 | -4,961 | -3,916 |
| Other Operating Activity | 10,251 | -1,943 | -19,686 | -610 | 35,155 |
| Operating Cash Flow | $-1,795 | $-17,302 | $22,458 | $37,842 | $83,626 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -790 | 19,842 | -1,376 | -10,739 | -4,657 |
| Purchase Of Investment | -284,314 | -382,014 | 7,300 | -4,589 | -329 |
| Sale Of Investment | 316,728 | 232,811 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -6 | -27 | -601 | -5,977 | -10,643 |
| Other Investing Activity | -6 | -27 | -601 | -5,977 | -10,643 |
| Investing Cash Flow | $31,618 | $-129,388 | $5,323 | $-21,305 | $-15,629 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 104,539 | N/A | N/A | N/A | 142,825 |
| Debt Repayment | -134,924 | N/A | N/A | N/A | -57,231 |
| Common Stock Issued | N/A | N/A | N/A | 4,718 | 2,791 |
| Other Financing Activity | -4,027 | -1,039 | -4,982 | -32,665 | -27,699 |
| Financing Cash Flow | $-34,412 | $-1,039 | $-4,982 | $-27,947 | $60,686 |
| Exchange Rate Effect | -2,210 | 2,128 | -7,381 | -1,825 | 2,128 |
| Beginning Cash Position | 61,741 | 207,342 | 191,924 | 205,159 | 74,348 |
| End Cash Position | 54,944 | 61,741 | 207,342 | 191,924 | 205,159 |
| Net Cash Flow | $-6,797 | $-145,601 | $15,418 | $-13,235 | $130,811 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,795 | -17,302 | 22,458 | 37,842 | 83,626 |
| Capital Expenditure | -790 | -1,437 | -1,376 | -10,739 | -4,657 |
| Free Cash Flow | -2,585 | -18,739 | 21,082 | 27,103 | 78,969 |